Rx Antihistamines Equally Efficacious, Safer Than OTCs - Blue Cross
This article was originally published in The Tan Sheet
Executive Summary
Data show that second-generation, low- and non-sedating antihistamines such as cetirizine (Pfizer's Zyrtec), loratadine (Schering-Plough's Claritin) and fexofenadine (Aventis' Allegra) are equally efficacious and less toxic than first-generation OTC antihistamines, according to an evidence report filed with FDA.
You may also be interested in...
Antihistamine OTC Switch Petition Slated For NDAC Debate May 11
FDA's decision to bring a citizen petition seeking OTC status of three low- and non-sedating antihistamine drugs before NDAC may be an attempt to apply public pressure on Schering-Plough, Aventis and Pfizer to accelerate any plans they may have to initiate switches on their own.
Antihistamine OTC Switch Petition Slated For NDAC Debate May 11
FDA's decision to bring a citizen petition seeking OTC status of three low- and non-sedating antihistamine drugs before NDAC may be an attempt to apply public pressure on Schering-Plough, Aventis and Pfizer to accelerate any plans they may have to initiate switches on their own.
Antihistamine OTC Switch Petition Slated For NDAC Debate May 11
FDA's decision to bring a citizen petition seeking OTC status of three low- and non-sedating antihistamine drugs before NDAC may be an attempt to apply public pressure on Schering-Plough, Aventis and Pfizer to accelerate any plans they may have to initiate switches on their own.